SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is seeing strong bullish sentiment as investors anticipate upcoming earnings, fueled by optimism over its AI infrastructure buildout and a raised price target from Morgan Stanley. While some traders are wary of potential volatility and high capital expenditure, many remain focused on the stock's long-term growth potential in the cloud sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

The conversation is dominated by anticipation for the upcoming Investor Day, with traders debating the company's growth strategy, recent acquisitions, and technological milestones. While some investors express bullish sentiment regarding the firm's leadership in the quantum sector and potential revenue expansion, others voice skepticism, questioning the company's financial fundamentals and technical progress compared to industry peers.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing and other quantum sector peers are rallying following the finalization of a 100 million dollar funding agreement with the U.S. Department of Commerce under the CHIPS and Science Act. While the broader quantum industry is trending, investors remain divided between optimistic sentiment regarding long-term technical potential and concerns over current valuation and bearish retail sentiment.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending following the finalization of a $100 million funding agreement with the U.S. Department of Commerce under the CHIPS and Science Act. While some traders view this government backing as a significant long-term validator for the company's quantum technology, others remain focused on the firm's financial volatility and ongoing management changes.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant price volatility and trending interest as the community debates the impact of competitor Novartis's Phase 3 DM1 trial failure on the broader muscular dystrophy space. While some traders fear a read-through risk that suggests a ceiling for DMPK knockdown therapies, others view the development as a competitive advantage for Sarepta and are looking toward upcoming clinical data readouts as a potential catalyst for a re-rating.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as traders react to its first-ever IPO underwriting role for Oura and significant growth in its prediction markets and Robinhood Chain fee revenue. The stock's recent rally has sparked intense debate, with bullish investors pointing to the company's expanding financial ecosystem while some retail traders continue to express skepticism and frustration rooted in past platform controversies.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the community highlights the FDA's acceptance of the Biologics License Application (BLA) for its hereditary angioedema (HAE) treatment, lonvoguran ziclumeran (lonvo-z), with Priority Review. Traders are expressing strong bullish sentiment regarding the company's progress toward commercialization, bolstered by a solid cash runway and significant institutional accumulation, while some continue to debate potential short squeeze dynamics given the stock's high short interest.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis is trending as investors react to the company's recent strategic $1.4 billion acquisition of Tourmaline Bio, which adds the Phase III cardiovascular drug pacibekitug to its pipeline, as well as the successful Phase III study results for its Sjögren's disease drug, ianalumab.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending amid renewed takeover speculation following a strong quarter of financial results and recent analyst upgrades. The community reaction remains highly polarized, with long-term shareholders debating the potential for a buyout against ongoing frustration regarding historical price performance and perceived market manipulation.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense bearish sentiment and significant selling pressure, with traders debating whether the stock's proximity to 52-week lows represents a prime value opportunity or a sign of terminal decline due to poor consumer spending, inflationary pressures, and health concerns. While bulls point to the company's real estate portfolio and historical dividend resilience as long-term support, bears argue that shifting consumer habits and macroeconomic headwinds could drive the stock significantly lower.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


baoxehoi

baoxehoi